title: Current status of hybrid coronary revascularization.
abstract: Hybrid coronary revascularization combines coronary artery bypass surgery with percutaneous coronary intervention techniques to treat coronary artery disease. The potential benefits of such a technique are to offer the patients the best available treatments for coronary artery disease while minimizing the risks of the surgery. Hybrid coronary revascularization has resulted in the establishment of new 'hybrid operating suites', which incorporate and integrate the capabilities of a cardiac surgery operating room with that of an interventional cardiology laboratory. Hybrid coronary revascularization has greatly augmented teamwork and cooperation between both fields and has demonstrated encouraging as well as good initial outcomes.
authors: Vanderbilt Heart and Vascular Institute, 1215 21st Avenue South, Nashville, TN 37232-8802, USA.
authors: Nikhil P
authors: NP
authors: Jaik
authors: Ramanan
authors: R
authors: Umakanthan
authors: Marzia
authors: M
authors: Leacche
authors: Natalia
authors: N
authors: Solenkova
authors: Jorge M
authors: JM
authors: Balaguer
authors: Steven J
authors: SJ
authors: Hoff
authors: Stephen K
authors: SK
authors: Ball
authors: David X
authors: DX
authors: Zhao
authors: John G
authors: JG
authors: Byrne
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000601:surgery*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors